FHIR
Release
3
(STU)
CI-Build
Medications
This
page
is
part
of
the
FHIR
Specification
(v3.0.2:
STU
3).
The
current
version
which
supercedes
this
version
is
5.0.0
.
For
a
full
list
Continuous
Integration
Build
of
available
versions,
see
FHIR
(will
be
incorrect/inconsistent
at
times).
See
the
Directory
of
published
versions
.
Page
versions:
R5
R4B
R4
R3
| Responsible Owner: Pharmacy Work Group |
|
Compartments : Encounter , Group , Patient , Practitioner |
Raw JSON ( canonical form + also see JSON Format Specification )
Order
Request
for
Intravenous
Chemotherapy
(inpatient
order)
-
Alemtuzumab
-
completed
with
multiple
dosageInstruction
lines
{
"resourceType": "MedicationRequest",
"id": "medrx0317",
"text": {
"status": "generated",
"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative with Details</b></p><p><b>id</b>: medrx0317</p><p><b>contained</b>: </p><p><b>identifier</b>: 12345689 (OFFICIAL)</p><p><b>status</b>: completed</p><p><b>intent</b>: order</p><p><b>medication</b>: id: med0303; Alemtuzumab 10mg/ml (Lemtrada) <span>(Details : {RxNorm code '1594660' = '1594660', given as 'Alemtuzumab 10mg/ml (Lemtrada)'})</span></p><p><b>subject</b>: <a>Donald Duck</a></p><p><b>authoredOn</b>: 15/01/2015</p><h3>Requesters</h3><table><tr><td>-</td><td><b>Agent</b></td><td><b>OnBehalfOf</b></td></tr><tr><td>*</td><td><a>Patrick Pump</a></td><td><a>Organization/f002</a></td></tr></table><p><b>reasonCode</b>: Chronic Lymphoid Leukemia (disorder) <span>(Details : {SNOMED CT code '92814006' = 'Chronic lymphoid leukemia', given as 'Chronic Lymphoid Leukemia (disorder)'})</span></p><p><b>dosageInstruction</b>: , , </p></div>"
},
"contained": [
{
"resourceType": "Medication",
"id": "med0303",
"code": {
"coding": [
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"code": "1594660",
"display": "Alemtuzumab 10mg/ml (Lemtrada)"
}
]
}
"resourceType" : "MedicationRequest",
"id" : "medrx0317",
"contained" : [{
"resourceType" : "Medication",
"id" : "med0303",
"code" : {
"coding" : [{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1594660",
"display" : "alemtuzumab 10 MG/ML [Lemtrada]"
}]
}
],
"identifier": [
{
"use": "official",
"system": "http://www.bmc.nl/portal/prescriptions",
"value": "12345689"
}],
"identifier" : [{
"use" : "official",
"system" : "http://www.bmc.nl/portal/prescriptions",
"value" : "12345689"
}],
"status" : "completed",
"intent" : "order",
"medication" : {
"reference" : {
"reference" : "#med0303"
}
],
"status": "completed",
"intent": "order",
"medicationReference": {
"reference": "#med0303"
},
"subject": {
"reference": "Patient/pat1",
"display": "Donald Duck"
"subject" : {
"reference" : "Patient/pat1",
"display" : "Donald Duck"
},
"authoredOn": "2015-01-15",
"requester": {
"agent": {
"reference": "Practitioner/f007",
"display": "Patrick Pump"
},
"onBehalfOf": {
"reference": "Organization/f002"
}
"authoredOn" : "2015-01-15",
"requester" : {
"reference" : "Practitioner/f007",
"display" : "Patrick Pump"
},
"reasonCode": [
{
"coding": [
{
"system": "http://snomed.info/sct",
"code": "92814006",
"display": "Chronic Lymphoid Leukemia (disorder)"
}
]
"reason" : [{
"concept" : {
"coding" : [{
"system" : "http://snomed.info/sct",
"code" : "92814006",
"display" : "Chronic lymphoid leukemia, disease (disorder)"
}]
}
],
"dosageInstruction": [
{
"sequence": 1,
"text": "Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk",
"additionalInstruction": [
{
"text": "Rapidly increase dose until tolerated"
}],
"dosageInstruction" : {
"step" : [{
"component" : [{
"text" : "Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk",
"additionalInstruction" : [{
"text" : "Rapidly increase dose until tolerated"
},
{
"text": "Administer on alternate days"
}
],
"timing": {
"repeat": {
"duration": 12,
"durationUnit": "wk",
"frequency": 3,
"period": 1,
"periodUnit": "wk"
}
},
"route": {
"coding": [
{
"system": "http://snomed.info/sct",
"code": "47625008",
"display": "Intravenous route (qualifier value)"
"text" : "Administer on alternate days"
}],
"timing" : {
"repeat" : {
"duration" : 12,
"durationUnit" : "wk",
"frequency" : 3,
"period" : 1,
"periodUnit" : "wk"
}
]
},
"method": {
"coding": [
{
"system": "http://snomed.info/sct",
"code": "422145002",
"display": "Inject - dosing instruction imperative (qualifier value)"
},
"route" : {
"coding" : [{
"system" : "http://snomed.info/sct",
"code" : "47625008",
"display" : "Intravenous route"
}]
},
"method" : {
"coding" : [{
"system" : "http://snomed.info/sct",
"code" : "422145002",
"display" : "Inject - dosing instruction imperative (qualifier value)"
}]
},
"doseAndRate" : [{
"type" : {
"coding" : [{
"system" : "http://terminology.hl7.org/CodeSystem/dose-rate-type",
"code" : "ordered",
"display" : "Ordered"
}]
},
"doseQuantity" : {
"value" : 3,
"unit" : "mg",
"system" : "http://unitsofmeasure.org",
"code" : "mg"
}
]
},
"doseQuantity": {
"value": 3,
"unit": "mg",
"system": "http://unitsofmeasure.org",
"code": "mg"
}
}]
}]
},
{
"sequence": 2,
"text": "Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk",
"additionalInstruction": [
{
"text": "Rapidly increase dose until tolerated"
"component" : [{
"text" : "Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk",
"additionalInstruction" : [{
"text" : "Rapidly increase dose until tolerated"
},
{
"text": "Administer on alternate days"
}
],
"timing": {
"repeat": {
"duration": 12,
"durationUnit": "wk",
"frequency": 3,
"period": 1,
"periodUnit": "wk"
}
},
"route": {
"coding": [
{
"system": "http://snomed.info/sct",
"code": "47625008",
"display": "Intravenous route (qualifier value)"
"text" : "Administer on alternate days"
}],
"timing" : {
"repeat" : {
"duration" : 12,
"durationUnit" : "wk",
"frequency" : 3,
"period" : 1,
"periodUnit" : "wk"
}
]
},
"method": {
"coding": [
{
"system": "http://snomed.info/sct",
"code": "422145002",
"display": "Inject - dosing instruction imperative (qualifier value)"
},
"route" : {
"coding" : [{
"system" : "http://snomed.info/sct",
"code" : "47625008",
"display" : "Intravenous route"
}]
},
"method" : {
"coding" : [{
"system" : "http://snomed.info/sct",
"code" : "422145002",
"display" : "Inject - dosing instruction imperative (qualifier value)"
}]
},
"doseAndRate" : [{
"type" : {
"coding" : [{
"system" : "http://terminology.hl7.org/CodeSystem/dose-rate-type",
"code" : "ordered",
"display" : "Ordered"
}]
},
"doseQuantity" : {
"value" : 10,
"unit" : "mg",
"system" : "http://unitsofmeasure.org",
"code" : "mg"
}
]
},
"doseQuantity": {
"value": 10,
"unit": "mg",
"system": "http://unitsofmeasure.org",
"code": "mg"
}
}]
}]
},
{
"sequence": 3,
"text": "Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk",
"additionalInstruction": [
{
"text": "Rapidly increase dose until tolerated"
"component" : [{
"text" : "Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk",
"additionalInstruction" : [{
"text" : "Rapidly increase dose until tolerated"
},
{
"text": "Administer on alternate days"
}
],
"timing": {
"repeat": {
"duration": 12,
"durationUnit": "wk",
"frequency": 3,
"period": 1,
"periodUnit": "wk"
}
},
"route": {
"coding": [
{
"system": "http://snomed.info/sct",
"code": "47625008",
"display": "Intravenous route (qualifier value)"
"text" : "Administer on alternate days"
}],
"timing" : {
"repeat" : {
"duration" : 12,
"durationUnit" : "wk",
"frequency" : 3,
"period" : 1,
"periodUnit" : "wk"
}
]
},
"method": {
"coding": [
{
"system": "http://snomed.info/sct",
"code": "422145002",
"display": "Inject - dosing instruction imperative (qualifier value)"
},
"route" : {
"coding" : [{
"system" : "http://snomed.info/sct",
"code" : "47625008",
"display" : "Intravenous route"
}]
},
"method" : {
"coding" : [{
"system" : "http://snomed.info/sct",
"code" : "422145002",
"display" : "Inject - dosing instruction imperative (qualifier value)"
}]
},
"doseAndRate" : [{
"type" : {
"coding" : [{
"system" : "http://terminology.hl7.org/CodeSystem/dose-rate-type",
"code" : "ordered",
"display" : "Ordered"
}]
},
"doseQuantity" : {
"value" : 30,
"unit" : "mg",
"system" : "http://unitsofmeasure.org",
"code" : "mg"
}
]
},
"doseQuantity": {
"value": 30,
"unit": "mg",
"system": "http://unitsofmeasure.org",
"code": "mg"
}
}
]
}]
}]
}]
}
}
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.
FHIR
®©
HL7.org
2011+.
FHIR
Release
3
(STU;
v3.0.2-11200)
R6
hl7.fhir.core#6.0.0-ballot3
generated
on
Thurs,
Oct
24,
2019
11:53+1100.
QA
Page
Wed,
Dec
17,
2025
09:54+0000.
Links:
Search
|
Version
History
|
Table
of
Contents
|
Credits
Glossary
|
QA
|
Compare
to
DSTU2
R4
|
Compare
to
R5
|
Compare
to
Last
Ballot
|
|
Propose
a
change